ANS-858 is a new selective, reversible, orally bioavailable ALDH2 Inhibitor in pre-clinical development to reduce craving. BEL AIR, Md. and SAN FRANCISCO, May 14, 2024 /PRNewswire/ -- Amygdala ...

BEL AIR, Md. and SAN FRANCISCO, May 14, 2024 /PRNewswire/ -- Amygdala Neurosciences (a private company) announced today that the Company has closed a new round of equity financing led by ABMRF ...

Gulshan Devaiah and Saiyami Kher's film is finally released on a digital platform on Friday, May 10, 2024. The film revolves around a touching story of two strangers forming a bond amidst the ...

The study emphasizes the hippocampus and amygdala’s roles in converting new, emotionally charged memories into familiar ones without the physical stress responses typical of wakefulness. These ...